- All sections
- C - Chemistrymetallurgy
- C08L - Compositions of macromolecular compounds
- C08L 5/10 - HeparinDerivatives thereof
Patent holdings for IPC class C08L 5/10
Total number of patents in this class: 79
10-year publication summary
2
|
6
|
8
|
5
|
4
|
3
|
7
|
10
|
9
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Board of Regents, The University of Texas System | 5828 |
6 |
Rensselaer Polytechnic Institute | 827 |
5 |
Allergan Pharmaceuticals International Limited | 227 |
4 |
University of Louisville Research Foundation, Inc. | 722 |
4 |
Momenta Pharmaceuticals, Inc. | 296 |
3 |
Otago Innovation Limited | 59 |
3 |
IHP Therapeutics Inc. | 4 |
3 |
Jiangnan University | 1531 |
2 |
Leibniz-institut fuer Polymerforschung Dresden e.V. | 14 |
2 |
Leibniz-institut fur Polymerforschung Dresden e.V. | 75 |
2 |
MERZ PHARMA GmbH & CO. KGaA | 608 |
2 |
Otsuka Pharmaceutical Factory, Inc. | 301 |
2 |
Sofradim Production | 291 |
2 |
Tega Therapeutics, Inc. | 15 |
2 |
Horizon IP, S.L | 3 |
2 |
Leibniz-institut für Polymerforschung e.V. | 3 |
2 |
Glycos Biomedical Ltd | 3 |
2 |
Centro Alta Tecnologia Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni S.r.l. | 2 |
2 |
L'OREAL, Société Anonyme | 15605 |
1 |
Industrial Technology Research Institute | 5081 |
1 |
Other owners | 27 |